Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial.
Kwaku Poku Asante, S. Abdulla, S. Agnandji, J. Lyimo +38 more
2011Lancet. Infectious Diseases (Print)128 citations
Semantic Scholar

